| Prev Close | 261.94 |
| Day Low/High | 259.84 / 265.68 |
| 52 Wk Low/High | 118.11 / 265.31 |
Veeva Systems Inc Class A (VEEV)
264.57
NYSE
| Exchange | NYSE |
| Shares Outstanding | 150.15B |
| Market Cap | 39.33B |
| P/E Ratio | 127.42 |
| Div & Yield | N.A. (N.A) |
Latest News
What to Expect When Marvell Technology Reports Thursday
I'll be taking at least a third of my long off ahead of the numbers this afternoon.
China Headline Risk, Valuation Station and a Workday Play
WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.
Viva Veeva Systems: Stock Looks Set to Climb Higher
In months ahead stock should rise, with price targets of $200, $215 and $235.
Go Long Veeva Systems on Strength as the Rally Could Extend Further
The technical signals for the technology provider to the life science industry show its shares have upside potential.
The Magic Mice of Regeneron
I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.
Sick Bond Market, What's Really Bad, Airlines in a Tailspin, Trading Thoughts
Would love to know if Warren Buffett is adding here, or keeping his powder dry. Would simply love to know.
The Fed's Bold Move, Trading Amazon in This Market, Owning Veeva Systems
Imagine not taking action to make commerce as liquid as possible ahead of a pending national crisis, because one was afraid to be perceived as panicked? The Fed was far from cowardly on Tuesday.
Can Markets Build From Here? G7 on Covid-19, Panic Buying Boosts Several Stocks
I would still like to see a day where the broad indices perform well on volume that grows from the day prior, but is that because I am too experienced?
Veeva Systems Is Ready to Emerge From a Basing Pattern
VEEV provides cloud-based software for the life sciences industry.
If You Buy Veeva Systems Here You Should Use a Sell Stop Below $137
Let's check out the charts.
Don't Be Fooled by the Indices, This Market Is Undergoing a Major Correction
There are times when the indices fail to tell the story of what is really going on.
Autodesk's Tumble Is a Reminder Cloud/SaaS Firms Can Face Macro Pressures Too
The CAD/CAM software giant is down sharply after blaming European and Chinese macro uncertainty for a slight cut in its full-year guidance.
Stay Patient With Veeva Systems
VEEV likely to correct for several more weeks, but an opportunity to buy may be awaiting.
AbbVie Fizzles, Gold, Bitcoin and (Some) Biotech Sizzles
AbbVie is dropping on Allergan deal announcement, momentum is weak outside certain pockets.
Salesforce: In the Cloud, Bigger and Broader Are Better Right Now
This cloud earnings season has been about the bigger established names.
Jim Cramer: Trump Doesn't Care About the Market Impact of Mexico Tariffs
These trade tariffs will have a big effect beyond just autos.
Do Short-Term Risks Equal Long-Term Opportunities in Veeva Systems?
Longs should protect their profits and positions in this name.
Sizing Up a Salesforce Earnings Reaction Trade
Traders should focus on the first-day post-earnings move.
Short-Selling Is Really Hard. Just Ask Citron Research
Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.
Veeva Systems Has More Room to Run on the Upside: Here's When to Buy
Prices could surprise traders and investors on the upside in the weeks ahead.
The Good Times Continue for VMware, Salesforce and Many Other Software Names
Recent earnings reports from several major software firms suggest business trends remain pretty good for the group.
Who's Next?: Acquisition Rumors Abound After IBM's $34 Billion Red Hat Splash
The momentum of acquisitions isn't stalling. Here's what names might be in the mix.
Jim Cramer: I Think That the Cloud Kings Remain Red Hot
I can see this group bottoming a heck of a lot faster than others.
Veeva Systems: Strong Fundamentals but Weakening Technicals
VEEV's price chart that is showing weakness.
More Tech Spec
I did want to hit up cannabis/Canada today, but I will be back same time, same channel next week, so I'm going to call an audible and push that until next week so I can finish up with my spec list today. 1) POTENTIAL BUYER: Intuit Potential Target: ...
10 Favorite Healthcare Stocks for 2018: Medical Marijuana to Opioid Treatment
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
